Circulating miR-765 and miR-149: Potential noninvasive diagnostic biomarkers for geriatric coronary artery disease patients

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Ali Sheikh, Md Sayed ^a   Xia, Ke ^a,b   Li, Fei ^a   Deng, Xu ^a   Salma, Umme ^c   Deng, Hai ^a   Wei Wei, Liu ^a   Yang, Tian Lun ^a   Peng, Jun ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Department of Medicine   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 149; MICRORNA 765; UNCLASSIFIED DRUG; MIRN149 MICRORNA, HUMAN; MIRN765 MICRORNA, HUMAN;

AGED; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; SMOKING HABIT; BLOOD; CASE CONTROL STUDY;

AGED; AREA UNDER CURVE; BIOMARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; MICRORNAS; ROC CURVE;

EID: 84947649145     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/740301     Document Type: Article

References (46)

1. A. S. Go, D. Mozaffarian, V. L. Roger et al., "Heart disease and stroke statistics 2013 update: a report from the American Heart Association," Circulation, vol. 127, pp. e6-e245, 2013.
2. A. S. M. Sayed, K. Xia, U. Salma, T. Yang, and J. Peng, "Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases," Heart, Lung and Circulation, vol. 23, no. 6, pp. 503-510, 2014.
3. B. Lindahl, "Acute coronary syndrome-the present and future role of biomarkers," Clinical Chemistry and Laboratory Medicine, vol. 51, no. 9, pp. 1699-1706, 2013.
4. D. Baek, J. Villén, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel, "The impact of microRNAs on protein output," Nature, vol. 455, no. 7209, pp. 64-71, 2008.
5. T. Thum, D. Catalucci, and J. Bauersachs, "MicroRNAs: novel regulators in cardiac development and disease," Cardiovascular Research, vol. 79, no. 4, pp. 562-570, 2008.
6. T. Alexy, K. Rooney, M. Weber et al., "TNF-α alters the release and transfer of microparticle -encapsulated miRNAs from endothelial cells," Physiological Genomics, vol. 46, pp. 833-840, 2014.
7. S. Dangwal, C. Bang, and T. Thum, "Novel techniques and targets in cardiovascular microRNA research," Cardiovascular Research, vol. 93, no. 4, pp. 545-554, 2012.
8. S. Kumar, C. W. Kim, R. D. Simmons et al., "Role of flowsensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, pp. 2206-2216, 2014.
9. J. Lee, S. Lim, B. W. Song et al., "MicroRNA-29b inhibits migration and proliferation of vascular smooth muscle cells in neointimal formation," Journal of Cellular Biochemistry, 2014.
10. K. di Gregoli, N. Jenkins, R. Salter et al., "MicroRNA-24 regulates macrophage behavior and retards atherosclerosis," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, pp. 1990-2000, 2014.
11. P. Zhang, C. Zheng, H. Ye et al., "MicroRNA-365 inhibits vascular smooth muscle cell proliferation through targeting cyclin D1," International Journal of Medical Sciences, vol. 11, no. 8, pp. 765-770, 2014.
12. N. B. Y. Tsui, E. K. O. Ng, and Y. M. D. Lo, "Stability of endogenous and added RNA in blood specimens, serum, and plasma," Clinical Chemistry, vol. 48, no. 10, pp. 1647-1653, 2002.
13. S. Fichtlscherer, A. M. Zeiher, and S. Dimmeler, "Circulating MicroRNAs: biomarkers or mediators of cardiovascular diseases?" Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 11, pp. 2383-2390, 2011.
14. S. Fichtlscherer, S. de Rosa, H. Fox et al., "Circulating microRNAs in patients with coronary artery disease," Circulation Research, vol. 107, no. 5, pp. 677-684, 2010.
15. J. Ren, J. Zhang, N. Xu et al., "Signature of circulatingMicroRNAs as potential biomarkers in vulnerable coronary artery disease," PLoS ONE, vol. 8, no. 12, Article IDe80738, 2013.
16. C. Widera, S. K. Gupta, J. M. Lorenzen et al., "Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome," Journal of Molecular and Cellular Cardiology, vol. 51, no. 5, pp. 872-875, 2011.
17. G.-K. Wang, J.-Q. Zhu, J.-T. Zhang et al., "Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans," European Heart Journal, vol. 31, no. 6, pp. 659-666, 2010.
18. Y. Goren, M. Kushnir, B. Zafrir, S. Tabak, B. S. Lewis, and O. Amir, "Serum levels of microRNAs in patients with heart failure," European Journal ofHeart Failure, vol. 14, no. 2, pp. 147-154, 2012.
19. M. F. Corsten, R. Dennert, S. Jochems et al., "Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease," Circulation: Cardiovascular Genetics, vol. 3, no. 6, pp. 499-506, 2010.
20. G. Long, F. Wang, Q. Duan et al., "Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acutemyocardial infarction," International Journal of Biological Sciences, vol. 8, no. 6, pp. 811-818, 2012.
21. A. J. Tijsen, E. E. Creemers, P.D. Moerland et al., "MiR423-5p as a circulating biomarker for heart failure," Circulation Research, vol. 106, no. 6, pp. 1035-1039, 2010.
22. K. L. Ellis, V. A. Cameron, R. W. Troughton, C. M. Frampton, L. J. Ellmers, and A. M. Richards, "Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients," European Journal of Heart Failure, vol. 15, no. 10, pp. 1138-1147, 2013.
23. A. Hsu, S. J. Chen, Y. S. Chang et al., "Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction," BioMed Research International, vol. 2014, Article ID418628, 13 pages, 2014.
24. S. D. Fihn, J. M. Gardin, J. Abrams et al., "ACCF/AHA/ACP/ AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines, and the AmericanCollege of Physicians, AmericanAssociation forThoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons," Journal of the American College of Cardiology, vol. 60, pp. e44-e164, 2012.
25. E. Braunwald, E. M. Antman, J. W. Beasley et al., "ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction- 2002: summary article: a report of the American College of Cardiology/AmericanHeartAssociation Task Force on Practice Guidelines (committee on the management of patients with unstable angina)," Circulation, vol. 106, no. 14, pp. 1893-1900, 2002.
26. O. Gidlöf, P. Andersson, J. Van Der Pals, M. Götberg, and D. Erlinge, "Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples," Cardiology, vol. 118, no. 4, pp. 217-226, 2011.
27. Y.-Q. Li, M.-F. Zhang, H.-Y. Wen et al., "Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acutemyocardial infarction," Clinics, vol. 68, no. 1, pp. 75-80, 2013.
28. R. Wang, N. Li, Y. Zhang, Y. Ran, and J. Pu, "Circulating microRNAs are promising novel biomarkers of acute myocardial infarction," Internal Medicine, vol. 50, no. 17, pp. 1789-1795, 2011.
29. G. Long, F. Wang, H. Li et al., "Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans," BMC Neurology, vol. 13, article 178, 2013.
30. P. Li, Q. Zhang, X. Wu et al., "Circulating microRNAs serve as novel biological markers for intracranial aneurysms," Journal of the AmericanHeart Association, vol. 3, Article IDe000972, 2014.
31. C. Wei, H. Henderson, C. Spradley et al., "Circulating miRNAs as potential marker for pulmonary hypertension," PLoS ONE, vol. 8, no. 5, Article IDe64396, 2013.
32. M. Y. Park, S. M. Herrmann, A. Saad et al., "Circulating and renal vein levels of microRNAs in patients with renal artery stenosis," Nephrology Dialysis Transplantation, 2014.
33. J. P.D. van Huyen, M. Tible, A. Gay et al., "MicroRNAs as noninvasive biomarkers of heart transplant rejection," European Heart Journal, 2014.
34. M. Abue, M. Yokoyama, R. Shibuya et al., "Circulating miR- 483-3p and miR-21 is highly expressed in plasma of pancreatic cancer," International Journal of Oncology, 2014.
35. M. Hoekstra, C. A. C. van der Lans, B. Halvorsen et al., "The peripheral blood mononuclear cell microRNA signature of coronary artery disease," Biochemical and Biophysical Research Communications, vol. 394, no. 3, pp. 792-797, 2010.
36. J. B. Redell, A. N. Moore, N. H. Ward, G. W. Hergenroeder, and P. K. Dash, "Human traumatic brain injury alters plasma microrna levels," Journal of Neurotrauma, vol. 27, no. 12, pp. 2147-2156, 2010.
37. H. Gu, H. Li, L. Zhang et al., "Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects," Journal of Neurochemistry, vol. 122, no. 3, pp. 641-649, 2012.
38. E. van Rooij, L. B. Sutherland, J. E. Thatcher et al., "Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 13027-13032, 2008.
39. C. Wu, Y. Gong, A. Sun et al., "The human MTHFR rs4846049 polymorphismincreases coronary heart disease risk through modifying miRNA binding," Nutrition, Metabolismand Cardiovascular Diseases, vol. 23, no. 7, pp. 693-698, 2013.
40. F. Olivieri, R. Antonicelli, M. Lorenzi et al., "Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction," International Journal of Cardiology, vol. 167, no. 2, pp. 531-536, 2013.
41. R. A. Boon, K. Iekushi, S. Lechner et al., "MicroRNA-34a regulates cardiac ageing and function," Nature, vol. 494, no. 7439, pp. 107-110, 2013.
42. A. S. M. Sayed, K. Xia, T.-L. Yang, and J. Peng, "Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction," Disease Markers, vol. 35, no. 5, pp. 561-566, 2013.
43. M. Udeanu, G. Guizzardi, G. di Pasquale et al., "Relationship between coronary artery disease andC-reactive protein levels in NSTEMI patients with renal dysfunction: a retrospective study," BMC Nephrology, vol. 15, article 152, 2014.
44. D. M. Moreira, R. L. da Silva, J. L. Vieira, T. Fattah, M. E. Lueneberg, and C. A. Gottschall, "Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the Prevention of atherothrombosis: inflammation and anti-inflammatory drugs in coronary artery disease," American Journal of Cardiovascular Drugs, 2014.
45. H. Wang, H.-Q. Zhu, F. Wang, Q. Zhou, S.-Y. Gui, and Y. Wang, "MicroRNA-1 prevents high-fat diet-induced endothelial permeability in apoE knock-out mice," Molecular and Cellular Biochemistry, vol. 378, no. 1-2, pp. 153-159, 2013.
46. R. Puri, S. E. Nissen, M. Shao et al., "Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy," American Journal of Cardiology, vol. 114, no. 10, pp. 1465-1472, 2014.